SCHEMBL15093443

SCHEMBL15093443

CCc1ccccc1OC(=O)Nc1cccc(C)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 1/20 0.56
▸ HTT P42858 3/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ LMNA P02545 2/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1954918 0.91 NLRP3 (0.52) NLRP3HTTTDP1POLBLMNA
SCHEMBL15093625 0.89 NLRP3 (0.53) NLRP3HTTTDP1POLBLMNA
SCHEMBL1955305 0.89 NLRP3 (0.50) NLRP3HTTTDP1POLBLMNA
SCHEMBL15105139 0.88 NLRP3 (0.50) NLRP3LMNANPC1RAB9AALDH1A1
SCHEMBL1953155 0.87 THRA (0.51) NLRP3HTTTDP1POLBLMNA
SCHEMBL1952991 0.87 NLRP3 (0.55) NLRP3HTTTDP1POLBLMNA
SCHEMBL1953123 0.86 THRA (0.53) NLRP3HTTPOLBLMNAALDH1A1
SCHEMBL1952597 0.86 THRA (0.53) NLRP3HTTPOLBLMNAALDH1A1
SCHEMBL1954276 0.86 THRA (0.53) NLRP3HTTPOLBLMNAALDH1A1
SCHEMBL1952617 0.86 THRA (0.53) NLRP3HTTPOLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2679575-B1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS ASAHI CHEMICAL IND (JP) 2019-04-10 — — EP disclosed
US-9714215-B2 Method for producing isocyanate ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-07-25 — — US disclosed
US-20160052874-A1 METHOD FOR PRODUCING ISOCYANATE ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-02-25 — — US disclosed
US-8957241-B2 Method for producing carbonyl compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-02-17 — — US disclosed
US-20130178645-A1 Method for Producing Carbonyl Compund ASAHI KASEI CHEMICALS CORPORATION (JP) 2013-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178645-A1 Method for Producing Carbonyl Compund CA6, CPS1, C9 NLRP3 2397/4885HTT 2396/4885TDP1 3915/4885
US-20160052874-A1 METHOD FOR PRODUCING ISOCYANATE CPS1, ALKBH3, IDH3A NLRP3 2368/4885HTT 351/4885TDP1 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback